{"meshTags":["Gene Rearrangement","Proto-Oncogene Proteins","Carcinoma, Non-Small-Cell Lung","Humans","Protein-Tyrosine Kinases","Lung Neoplasms"],"meshMinor":["Gene Rearrangement","Proto-Oncogene Proteins","Carcinoma, Non-Small-Cell Lung","Humans","Protein-Tyrosine Kinases","Lung Neoplasms"],"genes":["ROS1 gene","ROS1","ROS1"],"publicationTypes":["Journal Article"],"abstract":"MAJOR FINDING: ROS1 chromosomal rearrangements define a molecular subtype of NSCLC.\nROS1 rearrangements tend to occur in younger, non-smoking NSCLC patients.\nROS1-positive NSCLC patients may benefit from crizotinib therapy.","title":"ROS1 gene rearrangement is identified in NSCLC.","pubmedId":"22585869"}